PR: Heidelberg Pharma Receives Milestone Payment from Partner Magenta
PR: Heidelberg Pharma Announces Participation at Various Conferences
PR: Annual General Meeting 2020 of Heidelberg Pharma Approves All Proposed Resolutions
AH: Heidelberg Pharma AG: Main Shareholder dievini Commits to Further Financing for Expansion of Proprietary Pipeline
PR: Heidelberg Pharma to Present at the Upcoming Virtual European Biotech Investor Day 2020
AH: Heidelberg Pharma AG Raises EUR 14.4 Million From Private Placement
AH: Heidelberg Pharma AG Plans Capital Increase to Fund Its ATAC Development Program
PR: Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2020
PR: Heidelberg Pharma AG: European Patent Office Grants Patent for Amatoxin Conjugates for Tumor Therapy
PR: Heidelberg Pharma Publishes Article on Chemical Amanitin Synthesis in Angewandte Chemie Journal
PR: Heidelberg Pharma Announces Financial Figures for Fiscal Year 2019 and Provides Business Update
PR: Heidelberg Pharma AG: US patent rights granted for diagnosis and treatment of patients with TP53/RNA polymerase II deletion
PR: Partner Magenta Therapeutics Presents Preclinical Data on Lead Clinical Candidate MGTA-117 Demonstrating Broad Tolerability and High Therapeutic Index
AH: Heidelberg Pharma AG Secures Financing Commitment from Its Main Shareholder dievini
